Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

158 projects found matching your search criteria :

  1. "One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Barbara Ewa Pucelik

    Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

  2. Evaluating the antibacterial activity of the bacteriophage protein targeting Staphylococcus aureus, including drug-resis...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Zuzanna Maria Kaźmierczak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  3. Click chemistry in microfluidic channels for the construction of nanomaterials against drug-resistant microbes.

    Call: PRELUDIUM BIS 5 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk

  4. One health surveillance approach on marine mammal, marine environmental and human antimicrobial resistance on the North ...

    Call: WEAVE-UNISONO , Panel: NZ7

    Principal investigator: dr Iwona Pawliczka vel Pawlik

    Uniwersytet Gdański

  5. Directed screening and evaluation of novel bactericidal compounds active againsttubercle bacilli and Mycobacterium absce...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Jarosław Dziadek

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  6. Inactivation of intracellular Staphylococcus aureus and staphylococcal enterotoxins with photoactivated compounds in mod...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Joanna Nakonieczna

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  7. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  8. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

    Call: OPUS 25 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Uniwersytet Warszawski, Wydział Biologii

  9. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polskiej Akademii Nauk

  10. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Krzysztof Nowicki

    Politechnika Warszawska, Wydział Chemiczny

  11. Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

    Call: PRELUDIUM 22 , Panel: NZ1

    Principal investigator: Piotr Maciej Chyży

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  12. unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Jakub Cebula

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  13. Conjugates of peptide nucleic acids with aminoglycosides and fluoroquinolones as a novel strategy to target multi-drug r...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Izabela Siekierska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  14. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  15. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Assessment of the risk of tolerance, resistance and co-selection under various stress conditions in Escherichia coli.

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Aleksandra Małgorzata Rapacka-Zdończyk

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  17. Plant bacterial endophytes as an important antibiotic-resistance dissemination vector

    Call: SONATA 18 , Panel: NZ9

    Principal investigator: dr Magdalena Marta Zalewska

    Uniwersytet Warszawski, Wydział Biologii

  18. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C...

    Call: PRELUDIUM BIS 4 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  19. Brain-targeted β‐hydroxy-β‐methylbutyrate administration in the prevention of insulin resistance development in the hypo...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Elżbieta Supruniuk

    Uniwersytet Medyczny w Białymstoku

  20. Regulatory network and interactome of inner membrane drug/metabolite transporters in bacteria – implications for physiol...

    Call: OPUS 23 , Panel: NZ2

    Principal investigator: dr hab. Aneta Agnieszka Bartosik

    Instytut Biochemii i Biofizyki Polskiej Akademii Nauk

  21. Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Magdalena Alicja Strachowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  22. Role of natural products in overcoming drug resistance in Mycobacterium tuberculosis

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Elwira Zofia Sieniawska

    Uniwersytet Medyczny w Lublinie

  23. Effect of exercise training on muscle regenerative activity in hemodialysis patients

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr hab. Wioletta Dziubek-Rogowska

    AKADEMIA WYCHOWANIA FIZYCZNEGO WE WROCŁAWIU

  24. Reserved antibiotics and critical priority pathogens in hospital wastewater as an indicator of sanitary-epidemiological ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Ewa Korzeniewska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

  25. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr Magdalena Olbryt

    Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy, Oddział w Gliwicach

  26. The role of Candida albicans' plasma membrane sphingolipids in the potentially new mechanism of drug resistance and in t...

    Call: OPUS 22 , Panel: NZ1

    Principal investigator: dr hab. Anna Janina Krasowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  27. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr hab. Carlo Vascotto

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  28. Nanospectroscopic imaging of native biological membranes: Is the cell membrane the key for understanding the mechanism o...

    Call: SONATA BIS 11 , Panel: ST4

    Principal investigator: dr Katarzyna Pogoda

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk

  29. Interventions to control the dynamics of antimicrobial resistance from chickens through the environment

    Call: CHIST-ERA2020 , Panel: NZ7

    Principal investigator: dr Marta Kuźmińska-Bajor

    Uniwersytet Przyrodniczy we Wrocławiu

  30. Ionophore coccidiostats: risk of CO-selection of antimicrobial resistance - Clinical impact and intervention strategies

    Call: CHIST-ERA2020 , Panel: NZ7

    Principal investigator: dr Jowita Niczyporuk

    Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy

  31. Specific Targeting of Antimicrobial Resistant Strains in situ using Targeted-Antibacterial-Plasmids

    Call: CHIST-ERA2020 , Panel: NZ7

    Principal investigator: dr Anna Marzec-Grządziel

    Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

  32. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  33. Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in pro...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  34. Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: dr Joanna Elżbieta Kałafut

    Uniwersytet Medyczny w Lublinie

  35. Relationship between ATPase activity stimulation and transport - the case of selective Medicago truncatula ABCG transpor...

    Call: PRELUDIUM 20 , Panel: NZ1

    Principal investigator: dr Konrad Mateusz Pakuła

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  36. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Karolina Pogorzelska

    Narodowy Instytut Leków

  37. Evaluation of contamination of Vistula River near Warsaw by pharmaceuticaly active compounds and metabolites

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: prof. Grzegorz Leszek Nałęcz-Jawecki

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  38. AXL receptor signaling in cancer cell growth and drug resistance

    Call: OPUS 20 , Panel: NZ3

    Principal investigator: prof. Marta Elżbieta Miączyńska

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  39. Propolis and polyphenols derived from this product as potential antifungal agents

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Piotr Szweda

    Politechnika Gdańska

  40. The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Magdalena - Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  41. Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Tomasz Marcin Wróbel

    Uniwersytet Medyczny w Lublinie

  42. Make an old drug great again – isoniazid/rifamycin-boron clusters conjugates – synthesis and antitubercular activity....

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Bogusława Olejniczak

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  43. Epidemiology and rapid spread of antimicrobial resistance amongAcinetobacter spp. strains in hospital units - analysis u...

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chmielarczyk

    Uniwersytet Jagielloński, Collegium Medicum

  44. Array-based genomic and transcriptomic profiling in pediatric acute myeloblastic leukemia in search of genes resposible ...

    Call: SONATA 2 , Panel: NZ5

    Principal investigator: dr Joanna Szczepanek

    Uniwersytet Mikołaja Kopernika w Toruniu

  45. The role of gut microbiota metabolite, trimethylamine N-oxide, in development of insulin resistance

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Robert Antoni Olek

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu

  46. Electroporation-based manipulation of drug resistance in cancer using novel nanosecondasymmetrical pulse sequences

    Call: DAINA 2 , Panel: NZ7

    Principal investigator: dr hab. Julita Kulbacka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny

  47. Studies on virulence and drug resistance of Staphylococcus aureus strains isolated from cases of infections in different...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Jadwiga Wójkowska-Mach

    Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński Collegium Medicum; Wydział Lekarski

  48. Digestate from agricultural biogas plants as a reservoir of drug-resistance – a real risk to the environment?

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Izabela Wolak

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

  49. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  50. Effect of the co-treatment of municipal wastewater and landfill leachate on the spread of ARGs in the environment

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Małgorzata Czatzkowska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy